Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
London, 15 January 2026 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, announced that it has achieved B scores in both Climate Change and Water Security categories in the 2025 Carbon Disclosure Project (CDP) assessment, maintaining strong environmental performance as CDP's methodology continues to evolve.
Achieving B-level scores in both categories requires robust governance frameworks, reliable data systems, and measurable action across operations. The Water Security score represents significant progress from earlier reporting cycles, demonstrating Hikma's strengthened approach to managing this critical resource - particularly notable given that a significant portion of the Group’s manufacturing footprint operates in water-scarce regions across the Middle East and North Africa.
"These results reflect Hikma’s sustained commitment to environmental excellence," said Tim Brooks, VP Sustainability at Hikma. "Our progress in Water Security is particularly significant given the pharmaceutical sector's reliance on this essential resource. While we're proud of this achievement, we recognise there is more work ahead. We remain committed to continuous improvement in our environmental performance and to maintaining transparency with our stakeholders as we advance our sustainability goals."
Hikma has been reporting to CDP since 2010, demonstrating a long-standing commitment to environmental transparency and accountability.